BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8137858)

  • 1. Immunohistochemical studies on the expression of HLA class I antigens in renal cell carcinoma: comparison of primary and metastatic tumor tissue.
    Buszello H; Ackermann R
    Eur Urol; 1994; 25(2):158-63. PubMed ID: 8137858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
    J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.
    Sáenz-López P; Gouttefangeas C; Hennenlotter J; Concha A; Maleno I; Ruiz-Cabello F; Cózar JM; Tallada M; Stenzl A; Rammensee HG; Garrido F; Cabrera T
    Tissue Antigens; 2010 Feb; 75(2):110-8. PubMed ID: 19912575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
    Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
    Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
    Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class I expression in primary and metastatic renal cell carcinoma.
    Buszello H; Ackermann R
    Investig Urol (Berl); 1994; 5():55-9. PubMed ID: 7719321
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA class I antigens expression in renal cell carcinoma: histopathological and clinical correlation.
    Brasanac D; Müller CA; Müller GA; Hadzi-Dzokic J; Markovic-Lipkovski J
    J Exp Clin Cancer Res; 1999 Dec; 18(4):505-10. PubMed ID: 10746977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
    Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
    Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
    Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
    Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HLA-G expression in renal cell carcinoma.
    Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
    Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HLA class-I antigens on renal cell carcinoma and non-transformed renal tissue.
    Buszello H; Ackermann R
    Eur Urol; 1992; 21(1):70-4. PubMed ID: 1606987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.
    Hanak L; Slaby O; Lauerova L; Kren L; Nenutil R; Michalek J
    Med Sci Monit; 2009 Dec; 15(12):CR638-43. PubMed ID: 19946235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
    Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
    Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response.
    Bukur J; Malenica B; Huber C; Seliger B
    Hum Immunol; 2003 Nov; 64(11):1081-92. PubMed ID: 14602239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
    Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
    Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-E expression and its clinical relevance in human renal cell carcinoma.
    Seliger B; Jasinski-Bergner S; Quandt D; Stoehr C; Bukur J; Wach S; Legal W; Taubert H; Wullich B; Hartmann A
    Oncotarget; 2016 Oct; 7(41):67360-67372. PubMed ID: 27589686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of major histocompatibility complex (MHC) antigens and their loss on culture in renal carcinoma.
    Angus R; Collins CM; Symes MO
    Eur J Cancer; 1993; 29A(15):2158-60. PubMed ID: 8297657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls.
    Goebel S; Kehlen A; Bluemke K; Altermann W; Schlaf G; Fischer K; Fornara P; Wullich B; Wach S; Taubert H
    Cancer Immunol Immunother; 2017 May; 66(5):565-571. PubMed ID: 28184970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.